Skip to main content

Table 3 Frequencies, odds ratios, and p-values of rs3752462genevariants among cases and controls under recessive, dominant, co-dominant, additive and allele models

From: Association of MYH9-rs3752462 polymorphisms with chronic kidney disease among clinically diagnosed hypertensive patients: a case-control study in a Ghanaian population

Model

Allele

Controls (n = 132)

Cases (n = 132)

cOR (95% CI)

aOR (95% CI)

Dominant model

wt/mt CT + mt/mt TT

97.7%

97.7%

1

1

wt/wt CC

2.3%

2.3%

1.00 (0.20–5.05)

1.10 (0.19–6.29)

Recessive

wt/mt CT + wt/wt CC

34.1%

82.6%

1

1

mt/mt TT

65.9%

17.4%

0.11 (0.06–0.19)**

0.12 (0.06–0.25)**

Co-dominant model

wt/mt CT + mt/mt TT

68.2%

19.7%

1

1

wt/mt CT

31.8%

80.3%

8.73 (4.97–15.36)**

7.82 (3.81–16.04)**

Additive model 1

wt/mt CT

93.3%

97.2%

1

1

wt/wt CC

6.7%

2.8%

0.40 (0.08–2.04)

0.41 (0.07–2.44)

Additive model 2

mt/mt TT

96.7%

88.5%

1

1

wt/wt CC

3.3%

11.5%

3.78 (0.71–20.0)

4.0 (0.64–24.89)

Allele Model

T-allele

97.7%

97.7%

1

1

C-allele

34.1%

82.6%

9.16 (5.15–16.30)**

8.29 (4.0–17.27)**

  1. mt mutant type, wt; ild type, CI confidence interval, cOR crude odds ratio, aOR adjusted odds ratio (adjusted for age, sex, family history of CKD, hypertensive control status, BMI, TC, HDL-C, LDL-C); ** p-value < 0.001